IDEXX LABORATORIES INC /DE Payments to Acquire Other Investments
IDEXX LABORATORIES INC /DE (IDXX) reported Payments to Acquire Other Investments of $5.00 million for the 3-month period ending 2018-12-31, per its 10-K filed 2020-02-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherInvestments · last filed 2020-02-14
- IDEXX LABORATORIES INC /DE payments to acquire other investments for the quarter ending 2018-12-31 was $5.00M.
- IDEXX LABORATORIES INC /DE payments to acquire other investments for fiscal 2010 was $300.00K.
| Period end | Payments to Acquire Other Investments 3 month | Payments to Acquire Other Investments 12 month |
|---|---|---|
| 2018-12-31 | $5.00M 10-K · filed 2020-02-14 | |
| 2010-12-31 | $300.00K 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |